Alan M. Solinger,Patrick J. Scannon,Robert J. Bauer
申请号：
US14042205
公开号：
US20140255391A1
申请日:
2013.09.30
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Disclosed are methods for the treatment and/or prevention of Type 2 diabetes, insulin resistance and disease states and conditions characterized by insulin resistance, obesity, hyperglycemia, hyperinsulinemia and Type 1 diabetes, comprising administering to a subject an effective amount of anti-IL-1β antibody or fragment thereof.
